Worth reading
72In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
632
¥ million (year-on-year increase in consolidated net sales)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFiscal year ending March 2027: second quarter8 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥4,911 million+14.8%
Operating profit¥159 million-41.5%
Ordinary income¥136 million-44.5%
Net income¥69 million-81.8%
Gross Profit Margin48.1 %
Operating profit margin3.2 %
Selling, general and administrative expenses¥2,203 million
Results for the three months of the current quarter
Net Sales
¥2,491 million
Payment revenue
¥1,693 million+49.2%
Merchant revenue
¥568 million-25.6%
Consulting revenue
¥230 million-40.6%
Recurring revenue
¥1,242 million+74.1%
Non-recurring revenue
¥1,018 million-14.0%
Consulting revenue
¥230 million-40.6%
Full-year earnings forecast
Net Sales
¥11,200 million
Gross profit
¥5,500 million
Operating profit
¥600 million
Ordinary income
¥530 million
Net income for the current fiscal year
¥480 million
EBITDA
¥840 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales43.9
Gross profit43
Operating profit26.5
Ordinary income25.7
Net income for the current fiscal year14.5
EBITDA28.7
Payment revenue42.5
Merchant revenue51
Consulting revenue39.2
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing as plannedBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Usage-based recurring revenue706
Fixed recurring revenue267
Non-recurring revenue-56
Consulting revenue-285
Cost of revenue233
Gross profit400
SG&A excluding WV fees308
WV fees205
Depreciation and amortization-81
Operating profit-113
New initiatives
- Plans to launch an issuer partnership model with Sumitomo Mitsui Card Company, Limited. TOKIUM has been selected for the first rollout.
- アルファリア and Sumitomo Mitsui Card Company, Limited are developing Pharma Trade Pay (provisional name), a payment service for pharmaceutical wholesalers and pharmaceutical manufacturers.
- Developing a gateway model for financial institutions that minimizes the impact on existing systems
Key KPIsA metric the company considers important as a management benchmark.
BtoB GTV
¥2,411 100 million+122.0%
Number of companies using the payment platform
126,135 companies+45.7%
Recurring revenue ratio
48.8 %
Recurring gross profit
¥1,575 million+117.7%
EBITDA
¥241 million-25.0%
Segment results
Payment
Net Sales
¥3,229 million+53.7%
Segment profit
¥58 million
Merchant
Net Sales
¥1,172 million-15.2%
Segment profit
¥100 million-65.5%
Consulting
Net Sales
¥509 million-35.9%
Segment profit
¥201 million-37.9%
Adjustments
¥-201 million
Medium-term management plan targets
Gross Profit Margin
50 % or higher
Actual results
48.1 %
Market Size / Share
Prescription drug wholesale market size
¥9.4 1 trillion
Target fiscal yearFiscal 2024
Number of employees
390 people
Change during the periodDown 5 from 395 at the end of 1Q of the fiscal year ending March 2027
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2027: second quarter |
| Net Sales | ¥4,911 million (YoY +14.8%) |
| Operating profit | ¥159 million (YoY -41.5%) |
| Ordinary income | ¥136 million (YoY -44.5%) |
| Net income | ¥69 million (YoY -81.8%) |
| Gross Profit Margin | 48.1 % |
| Operating profit margin | 3.2 % |
| Selling, general and administrative expenses | ¥2,203 million |
| Results for the three months of the current quarter | Net Sales ¥2,491 million / Payment revenue ¥1,693 million (YoY +49.2%) / Merchant revenue ¥568 million (YoY -25.6%) / Consulting revenue ¥230 million (YoY -40.6%) / Recurring revenue ¥1,242 million (YoY +74.1%) / Non-recurring revenue ¥1,018 million (YoY -14.0%) / Consulting revenue ¥230 million (YoY -40.6%) |
| Full-year earnings forecast | Net Sales ¥11,200 million / Gross profit ¥5,500 million / Operating profit ¥600 million / Ordinary income ¥530 million / Net income for the current fiscal year ¥480 million / EBITDA ¥840 million |
| Progress against full-year forecast | Net Sales 43.9 / Gross profit 43 / Operating profit 26.5 / Ordinary income 25.7 / Net income for the current fiscal year 14.5 / EBITDA 28.7 / Payment revenue 42.5 / Merchant revenue 51 / Consulting revenue 39.2 |
| Self-assessment against the plan | Progressing as planned |
| Segment results | Payment Net Sales ¥3,229 million (YoY +53.7%) / Segment profit ¥58 million / Merchant Net Sales ¥1,172 million (YoY -15.2%) / Segment profit ¥100 million (YoY -65.5%) / Consulting Net Sales ¥509 million (YoY -35.9%) / Segment profit ¥201 million (YoY -37.9%) / Adjustments ¥-201 million |
| Breakdown of Factors Affecting the Change | Usage-based recurring revenue 706 / Fixed recurring revenue 267 / Non-recurring revenue -56 / Consulting revenue -285 / Cost of revenue 233 / Gross profit 400 / SG&A excluding WV fees 308 / WV fees 205 / Depreciation and amortization -81 / Operating profit -113 |
| Key KPIs | BtoB GTV ¥2,411 100 million (YoY +122.0%) / Number of companies using the payment platform 126,135 companies (YoY +45.7%) / Recurring revenue ratio 48.8 % / Recurring gross profit ¥1,575 million (YoY +117.7%) / EBITDA ¥241 million (YoY -25.0%) |
| Number of employees | 390 people |
| Medium-term management plan targets | Gross Profit Margin 50 % or higher / Actual results 48.1 % |
| Market Size / Share | Prescription drug wholesale market size ¥9.4 1 trillion |
| New initiatives | Plans to launch an issuer partnership model with Sumitomo Mitsui Card Company, Limited. TOKIUM has been selected for the first rollout., アルファリア and Sumitomo Mitsui Card Company, Limited are developing Pharma Trade Pay (provisional name), a payment service for pharmaceutical wholesalers and pharmaceutical manufacturers., Developing a gateway model for financial institutions that minimizes the impact on existing systems |
Items this document does not state (11)
Unit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The strong growth in B2B GTV increased usage-based recurring revenue, driving sales growth in the Payment business. On the profit side, results were affected by the decline following the high-value-added projects recorded in the same period of the previous year, the reaction to sales of payment terminals for taxis that had been introduced ahead of schedule in the same period of the previous year, the reallocation of consulting personnel and an increase in intra-group transactions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.